UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000007384
Receipt number R000008702
Scientific Title A randomized controlled clinical trial to examine the microbiological and clinical effects of oral antimicrobials on patients with periodontitis receiving supportive periodontal therapy
Date of disclosure of the study information 2012/03/10
Last modified on 2016/03/27 11:44:42

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A randomized controlled clinical trial to examine the microbiological and clinical effects of oral antimicrobials on patients with periodontitis receiving supportive periodontal therapy

Acronym

A clinical trial to examine the effects of oral antimicrobials on patients with periodontitis in SPT phase

Scientific Title

A randomized controlled clinical trial to examine the microbiological and clinical effects of oral antimicrobials on patients with periodontitis receiving supportive periodontal therapy

Scientific Title:Acronym

A clinical trial to examine the effects of oral antimicrobials on patients with periodontitis in SPT phase

Region

Japan


Condition

Condition

Moderate to severe periodontitis

Classification by specialty

Dental medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the effects of 2 different oral antimicrobials on microbiological and clinical parameters in patients with periodontitis in SPT phase.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The number of total bacteria and some periodontopathic bacteria in subgingival plaque

Key secondary outcomes

Probing pocket depth(PD)
Bleeding on probing(BOP)
Antibody levels in serum against periodontopathic bacteria Concentration of the drugs in gingival crevicular fluid


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit


Blinding

Open -but assessor(s) are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Test group
1. 25 patients
2. Patients take 500mg of test drug per day, once a day for 3 days

Interventions/Control_2

Control group
1. 25 patients.
2. Patients take 200mg of sitafloxacin hydrate (Gracevit) per day for 5 days.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. 20 years or older persons who obtained written informed consent.
2. Persons who have diagnosed as moderate to severe chronic or aggressive periodontitis.
3. Persons who have completed active periodontal treatment and received SPT.
4. Persons who have more than 15 teeth.
5. Persons who have more than 2 teeth with PD more than 5mm and BOP (+)

Key exclusion criteria

1. Persons who received debridement in periodontal pockets for the past one month prior to this study.
2. Persons who received SRP with local anesthesia for the past three month prior to this study.
3. Persons who took antimicrobials (except external use) for the past three month prior to this study.
4. Persons who have the medical history of hypersensitivity to new quinolone or macrolide antimicrobials.
5. Persons who are pregnant or suspected to be pregnant.
6. Persons who have severe diabetes, heart diseases, or dysfunction of kidney or liver.
7. Persons who are judged to be unqualified for this study subjects by investigators.

Target sample size

50


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kazuhisa Yamazaki

Organization

Niigata University

Division name

Graduate school of medical and oral sciences,

Zip code


Address

2-5274, Gakkocho-dori, Chuo-ku, Niigata, 951-8514, Japan

TEL

025-227-6161

Email

kaz@dent.niigata-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Takako Nakajima

Organization

Niigata University

Division name

Medical and dental hospital,

Zip code


Address

2-5274, Gakkocho-dori, Chuo-ku, Niigata, 951-8514, Japan

TEL

025-227-6161

Homepage URL


Email

takako@dent.niigata-u.ac.jp


Sponsor or person

Institute

Niigata University Medical and Dental Hospital

Institute

Department

Personal name



Funding Source

Organization

Daiichi-Sankyo Co., LTD

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2012 Year 03 Month 10 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications

http://aac.asm.org/content/early/2016/01/04/AAC.02575-15.abstract

Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2011 Year 09 Month 28 Day

Date of IRB


Anticipated trial start date

2011 Year 11 Month 01 Day

Last follow-up date

2014 Year 11 Month 30 Day

Date of closure to data entry

2014 Year 12 Month 31 Day

Date trial data considered complete

2015 Year 02 Month 28 Day

Date analysis concluded

2015 Year 02 Month 28 Day


Other

Other related information



Management information

Registered date

2012 Year 02 Month 27 Day

Last modified on

2016 Year 03 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000008702


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name